NCT00003205View on ClinicalTrials.gov

Bryostatin 1 in Treating Patients With Stage IV Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1998

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Breast Cancer
Interventions
DRUG

bryostatin 1

Trial Locations (1)

80010

University of Colorado Cancer Center, Denver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER

NCT00003205 - Bryostatin 1 in Treating Patients With Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter